Cite
Serum creatinine as a biomarker for dystrophinopathy: a cross-sectional and longitudinal study.
MLA
Wang, Liang, et al. “Serum Creatinine as a Biomarker for Dystrophinopathy: A Cross-Sectional and Longitudinal Study.” BMC Neurology, vol. 21, no. 1, Sept. 2021, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s12883-021-02382-7.
APA
Wang, L., Xu, M., Liu, D., Liang, Y., Feng, P., Li, H., Zhu, Y., He, R., Lin, J., Zhang, H., Liao, Z., & Zhang, C. (2021). Serum creatinine as a biomarker for dystrophinopathy: a cross-sectional and longitudinal study. BMC Neurology, 21(1), 1–11. https://doi.org/10.1186/s12883-021-02382-7
Chicago
Wang, Liang, Min Xu, Dawei Liu, Yingyin Liang, Pinning Feng, Huan Li, Yuling Zhu, et al. 2021. “Serum Creatinine as a Biomarker for Dystrophinopathy: A Cross-Sectional and Longitudinal Study.” BMC Neurology 21 (1): 1–11. doi:10.1186/s12883-021-02382-7.